Combination of MTP inhibitors or apoB-secretion inhibitors with fibrates for use as pharmaceuticals
申请人:Boehringer Ingelheim Pharma KG
公开号:US20030162788A1
公开(公告)日:2003-08-28
The invention relates to the use of fibrates for lowering the liver toxicity of MTP inhibitors as well as pharmaceutical compositions containing an MTP inhibitor and a fibrate.
本发明涉及使用纤维酸衍生物来降低MTP抑制剂对肝脏的毒性,以及包含MTP抑制剂和纤维酸衍生物的药物组合物。